MODICA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 418
EU - Europa 177
AS - Asia 63
OC - Oceania 3
AF - Africa 1
Totale 662
Nazione #
US - Stati Uniti d'America 415
IT - Italia 66
IE - Irlanda 40
CN - Cina 27
SE - Svezia 23
FR - Francia 9
SG - Singapore 9
PL - Polonia 8
VN - Vietnam 8
HK - Hong Kong 7
GB - Regno Unito 6
AT - Austria 5
DE - Germania 4
JP - Giappone 4
BE - Belgio 3
CA - Canada 3
HU - Ungheria 3
PK - Pakistan 3
UA - Ucraina 3
AU - Australia 2
ES - Italia 2
FI - Finlandia 2
CZ - Repubblica Ceca 1
HR - Croazia 1
IN - India 1
IR - Iran 1
KR - Corea 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SN - Senegal 1
TH - Thailandia 1
TR - Turchia 1
Totale 662
Città #
Chandler 54
Fairfield 42
Dublin 40
Ashburn 20
Seattle 17
Torino 17
Cambridge 16
Ann Arbor 15
Houston 15
Turin 15
Dearborn 13
Nyköping 13
Woodbridge 13
Beijing 10
Wilmington 10
Medford 8
New York 8
Princeton 7
Boston 6
Florence 5
San Diego 5
Vienna 5
Dong Ket 4
Los Angeles 4
Luni 4
Pisa 4
Wroclaw 4
Boerne 3
Brussels 3
Milan 3
San Francisco 3
Silver Spring 3
Tokyo 3
Upper Marlboro 3
Villeurbanne 3
Central 2
Edinburgh 2
Etobicoke 2
Fremont 2
Guangzhou 2
Hangzhou 2
Jacksonville 2
Norwalk 2
Porterville 2
Redwood City 2
Reutlingen 2
Serio 2
Shanghai 2
Singapore 2
Warsaw 2
Xian 2
Amiens 1
Amsterdam 1
Anaheim 1
Andover 1
Auckland 1
Baltimore 1
Bangkok 1
Barcelona 1
Birmingham 1
Boardman 1
Brumley 1
Budapest 1
Cagliari 1
Central District 1
Duncan 1
Frederick 1
Fuzhou 1
Glen Mills 1
Gubin 1
Hanover 1
Hefei 1
Helsinki 1
Islamabad 1
Istanbul 1
Lexington 1
London 1
Madrid 1
Manchester 1
Marseille 1
Mohanpur 1
Ottawa 1
Otterstadt 1
Paesana 1
Palermo 1
Philadelphia 1
Phoenix 1
Port Lavaca 1
Rome 1
San Antonio 1
San Mateo 1
Seoul 1
Sydney 1
Troy 1
Trzebnica 1
Villar San Costanzo 1
Voulangis 1
Washington 1
Zagreb 1
Totale 478
Nome #
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody 149
MET/HGF co-targeting in pancreatic cancer: A tool to provide insight into the tumor/stroma crosstalk 123
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy 95
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells 77
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours 77
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers 52
Hgf/met axis induces tumor secretion of tenascin-c and promotes stromal rewiring in pancreatic cancer 43
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy 33
A receptor-antibody hybrid hampering MET-driven metastatic spread 30
Totale 679
Categoria #
all - tutte 2.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 5 11 6
2019/202098 4 1 5 12 10 14 9 14 13 7 5 4
2020/202189 3 8 4 5 9 4 4 7 5 16 6 18
2021/2022132 7 3 1 5 2 14 6 4 3 11 59 17
2022/2023235 12 19 5 14 24 46 17 32 32 7 18 9
2023/202481 12 16 4 8 6 19 7 2 0 7 0 0
Totale 679